Found 12 matching trials
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia PHASE1 Background:
Sickle cell disease (SCD) is an inherited disorder of the bloo...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide PHASE2 This is a prospective, multi-center, Phase II study of hematopoietic cell t...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center
Learn More & Join Trial
Validation of Radio-induced Damage Biomarkers NA The aim of this study is to confirm in humans the relevance and the kinetic...
Show More Location
Institut de Cancérologie Lucien Neuwirth
Learn More & Join Trial
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation PHASE2 The purpose of this clinical trial is to compare drug combinations to learn...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Cord Blood Transplantation in Children and Young Adults With Blood Cancer PHASE2 The purpose of this study is to find out whether Cord Blood Transplantation...
Show More Location
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Learn More & Join Trial
NK Cells in Cord Blood Transplantation PHASE1 This phase I trial studies the side effects and best way to give natural ki...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies NA The purpose of this study is to determine the safety and effectiveness of U...
Show More Location
Multiple Locations
Learn More & Join Trial
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders PHASE2 This is a phase II trial of T cell receptor alpha/beta depletion (α/β TCD) ...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders PHASE2 This phase II trial studies fludarabine phosphate and total-body irradiatio...
Show More Location
Children's Hospital and Research Center at Oakland
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis PHASE2 The goal of this clinical trial is to determine the effectiveness of Reduce...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Learn More & Join Trial